Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis

Annals of Diagnostic Pathology

Volumn 16, Issue 1, 2012, Pages 29-37

  Wang, Huamin ^a   Zhao, Qing ^a   Rashid, Asif ^a   Gong, Yun ^a   Katz, Matthew H ^a   Lee, Jeffrey E ^a   Wolf, Robert ^a   Balachandran, Aparna ^a   Varadhachary, Gauri R ^a   Pisters, Peter W ^a   Wang, Hua ^a   Gomez, Henry F ^a   Abbruzzese, James L ^a   Fleming, Jason B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Pancreatic cancer; Pathologic complete response; Prognosis; Survival

Indexed keywords

CISPLATIN; CYTOKERATIN 7; FLUOROURACIL; GEMCITABINE;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BONE METASTASIS; BRAIN METASTASIS; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAUNDICE; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PANCREATIC DUCTAL ADENOCARCINOMA; PANCREATIC INTRAEPITHELIAL CARCINOMA IN SITU; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PANCREATICODUODENECTOMY; PANCREATITIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SEPSIS; THERAPY EFFECT; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84856019443     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2011.08.005     Document Type: Article

References (30)

1. Jemal A. Cancer statistics, 2008 CA Cancer J Clin 58 2 2008 71 96 (Pubitemid 351521864)
2. Jemal A. Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
3. Geer R.J., and M.F. Brennan Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 1 1993 68 72 [discussion 72-3]
4. Crist D.W., J.V. Sitzmann, and J.L. Cameron Improved hospital morbidity, mortality, and survival after the Whipple procedure Ann Surg 206 3 1987 358 365 (Pubitemid 17159710)
5. Traverso L.W. Intraoperative cholangiography lowers the risk of bile duct injury during cholecystectomy Surg Endosc 20 11 2006 1659 1661 (Pubitemid 44715525)
6. Bilimoria K.Y. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database Cancer 110 4 2007 738 744 (Pubitemid 47257648)
7. Evans D.B. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 21 2008 3496 3502
8. Varadhachary G.R. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 21 2008 3487 3495
9. Corsini M.M. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005) J Clin Oncol 26 21 2008 3511 3516
10. Aschele C. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 2011 2773 2780
11. Garcia-Aguilar J. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 3 2003 298 304 (Pubitemid 36331646)
12. Meredith K.L. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer Ann Surg Oncol 17 4 2010 1159 1167
13. Symmans W.F. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol 25 28 2007 4414 4422 (Pubitemid 350013847)
14. Wu T.T. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome Am J Surg Pathol 31 1 2007 58 64
15. Evans D.B. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 11 1992 1335 1339
16. Hruban R.H., and N. Fukushima Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs Mod Pathol 20 Suppl 1 2007 S61 S70 (Pubitemid 46733656)
17. Hruban R.H. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms Am J Surg Pathol 28 8 2004 977 987 (Pubitemid 38971421)
18. Singh M., and A. Maitra Precursor lesions of pancreatic cancer: molecular pathology and clinical implications Pancreatology 7 1 2007 9 19 (Pubitemid 46725717)
19. Sipos B. Pancreatic intraepithelial neoplasia revisited and updated Pancreatology 9 1-2 2009 45 54
20. Pisters P.W. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma J Clin Oncol 16 12 1998 3843 3850 (Pubitemid 29001537)
21. Wolff R.A., G.R. Varadhachary, and D.B. Evans Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress Ann Surg Oncol 15 10 2008 2773 2786
22. Pisters P.W. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome J Clin Oncol 20 10 2002 2537 2544 (Pubitemid 34525741)
23. Crane C.H. The integration of chemoradiation in the care of patient with localized pancreatic cancer Cancer Radiother 13 2 2009 123 143
24. Tinkl D. Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation Strahlenther Onkol 185 9 2009 557 566
25. Chari R.S. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum Ann Surg 221 6 1995 778 786 [discussion 786-7]
26. Hyams D.M. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03 Dis Colon Rectum 40 2 1997 131 139 (Pubitemid 27074280)
27. Janjan N.A. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer Radiother Oncol 51 2 1999 153 160 (Pubitemid 29320309)
28. Sato I. Curatively resected case of non-functioning pancreatic neuroendocrine carcinoma with multiple liver metastases after downstaging with S-1 monotherapy Gan To Kagaku Ryoho 37 7 2010 1341 1344
29. Mendenhall W.M. Role of radiation therapy in the treatment of resectable rectal adenocarcinoma J Surg Oncol 79 2 2002 107 117 [discussion 118] (Pubitemid 34111936)
30. Estrella J.S. Posttherapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation Cancer 2011 Epub ahead of print [ doi:10.1002/cncr.26243 ]